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Parasternal intercostal muscle 
ultrasound in chronic obstructive 
pulmonary disease correlates with 
spirometric severity
Peter Wallbridge  1,2, Selina M. Parry3, Sourav Das4, Candice Law5, Gary Hammerschlag1, 
Louis Irving1,2, Mark Hew2,6 & Daniel Steinfort1,2
In chronic obstructive pulmonary disease (COPD), loss of computed tomography (CT)-measured 
intercostal mass correlates with spirometric severity. Intercostal muscle ultrasound offers a repeatable 
and radiation-free alternative, however requires validation. We aimed to determine the reliability 
of parasternal intercostal muscle ultrasound, and the concurrent validity of parasternal ultrasound 
with clinicometric parameters. Twenty stable COPD patients underwent ultrasound measurement of 
thickness and echogenicity of 2nd and 3rd parasternal intercostal muscles, dominant pectoralis major 
and quadriceps, and diaphragm thickness; spirometry; and chest CT. Intra-rater intraclass correlation 
(ICC) for ultrasound intercostal thickness was 0.87–0.97 depending on site, with echogenicity ICC 
0.63–0.91. Inter-rater ICC was fair to excellent. Ultrasound intercostal thickness moderately correlated 
with FEV1% predicted (r = 0.33) and quadriceps thickness (r = 0.31). Echogenicity correlated negatively 
with FEV1% predicted (r = −0.32). CT-measured lateral intercostal mass correlate negatively with 
parasternal ultrasound intercostal thickness. These data confirm ultrasound of parasternal intercostal 
musculature is reproducible. Lower intercostal muscle quantity and quality reflects greater COPD 
spirometric severity. This novel tool may have biomarker potential for both the systemic effects of 
COPD on muscle as well as local disruption of respiratory mechanics. The negative correlation between 
CT and ultrasound measurements may reflect complex site-dependent interactions between respiratory 
muscles and the chest wall.
Chronic obstructive pulmonary disease (COPD) is characterised by non-reversible airflow obstruction with per-
sistent respiratory symptoms1 and associated extra-pulmonary effects of weight loss and muscle wasting, reflect-
ing its systemic impact. In COPD, impaired muscle strength and composition (muscle quality) is associated with 
poorer clinical outcomes2,3 and increased healthcare utilization4.
Bedside ultrasonography enables evaluation of muscle quantity and composition5–7, with increasing muscle 
echogenicity (a measure of muscle quality, with higher scores indicating poorer muscle quality) associated with 
increased muscle fat infiltration in healthy individuals8 as well as in critical illness9. Dynamic changes in muscle 
cross-sectional area and echogenicity correlate with strength and function during critical illness10.
In COPD, ultrasound quadriceps bulk is reduced compared to controls11, and predicts readmissions and mortal-
ity12. Increased echogenicity is associated with higher spirometry-defined COPD severity13, and low muscle attenu-
ation on computed tomography (CT) (reflecting poorer quality muscle), is more common than in control subjects14.
Changes in chest wall musculature may reflect combined systemic effects and local disruption of respiratory 
mechanics due to airflow obstruction and hyperinflation in COPD. Imaging of thoracic musculature may there-
fore be more instructive than peripheral musculature. Animal models have established the impact of increasing 
lung volume on the ability of intercostal muscles to alter airway opening pressure in addition to a reduction in the 
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ability of the diaphragm to generate force15. It has been shown that a lower mass of intercostal muscles measured 
by CT correlates with greater COPD spirometric severity16, and exacerbation frequency17. However CT assess-
ment of intercostal muscles is resource intensive, generally requires specialized expertise, exposes patients to 
ionizing radiation, and cannot be repeated frequently.
Ultrasound overcomes many of these drawbacks given its lack of ionising radiation, portability, and ability to 
examine other relevant muscle groups including the diaphragm and quadriceps. Chest ultrasound is already in 
routine clinical use for the investigation and management of pleural and parenchymal lung disease18–22. In healthy 
volunteers, ultrasound has been used to study intercostal muscles in the easily-accessible anterior parasternal 
region, but is yet to be applied to patients with COPD23,24.
In this pioneering study, we aimed to demonstrate feasibility and reproducibility of sonographic measure-
ment of parasternal intercostal muscles in patients with COPD. We hypothesised that ultrasound measurement 
of parasternal intercostal muscles would be feasible in patients with COPD and have high intra- and inter-rater 
reliability. We also hypothesised that ultrasound intercostal muscle quantity measured by thickness, and quality 
(measured by grayscale analysis), would reflect spirometric COPD severity.
Methods
Ultrasound examination was performed on 20 patients with stable COPD recruited from the respiratory clinic 
of a university-affiliated tertiary referral hospital in Melbourne, Australia. We included patients aged >18 years 
with COPD confirmed by spirometry (post-bronchodilator forced expiratory ratio <70%)1. Participants were 
required to have undergone chest CT within 6 months of enrolment. We excluded patients with an exacerbation 
of COPD requiring antibiotic or oral corticosteroid therapy within previous 6 months, or inability to provide 
informed consent. Baseline demographic data, short-form international physical activity questionnaire (IPAQ 
or IPAQ-Elderly for patients aged ≥65 years) and Charlson comorbidity index were obtained. Informed consent 
was obtained from all participants, and this project and its’ protocol received ethics approval by the Melbourne 
Health Human Research Ethics Committee (LNR/15/MH/405) and was carried out in accordance with local and 
national guidelines and regulations. The reporting of this study was in line with COnsus-based Standards for the 
selection of health Measurement INstruments (COSMIN) guidelines25.
Ultrasound examination. Ultrasound was performed by a single operator (PW) with 8 years of ultrasound 
experience and qualifications in respiratory ultrasound. B-mode images were obtained utilising a 6–14 mHz linear 
array on a MindRay TE-5 machine (Shenzhen Mindray Bio-Medical Electronics Co. Ltd. Shenzen, China) with 
the participant at 45 degrees. Depth and gain were standardised using the same image presets between patients.
Still images were taken of the 2nd and 3rd parasternal intercostal muscles bilaterally in the sagittal plane at 
end-tidal inspiration with a window visualising the 2nd/3rd, and 3rd/4th ribs respectively (Fig. 1); dominant pec-
toralis major muscle (sagittal plane at the mid-point of the muscle), diaphragm thickness (end-tidal expiration 
in the right anterior axillary line between the 8th and 9th ribs in the coronal plane)26, and quadriceps (vastus 
intermedius and rectus femoris thickness and echogenicity) approximately 15 cm above the superior border of 
the patella. (Fig. 2) All sites were imaged twice to allow for assessment of intra-operator reliability, with the probe 
removed from the patient between measurements with less than 1 minute between scans and no change in patient 
condition or positioning. Subcutaneous fat thickness was measured at all sites.
Measurements were performed on stored images using freely available ImageJ software (https://imagej.nih.
gov/ij/index.html NIH, Bethesda, MD, USA). Muscle thickness in millimetres was between the inner and out-
ermost echogenic layer of the muscle fascial borders. Muscle echogenicity was calculated utilising the square 
method27 to define the region of interest for analysis using ImageJ histogram function (Fig. 3). Images were 
reviewed by a second reader (GH) with respiratory ultrasound experience to assess inter-rater reliability.
Images from CTs were reviewed by a chest radiologist (CL) blinded to ultrasound results, who identified the 
outline of the third to eighth internal intercostal muscles in the plane of the lateral arc of the first rib as previously 
described by Park16 (Fig. 4). Within this region of interest, muscle area was recorded utilising a Hounsfield unit 
threshold of −29 to +150HU28. Both total CT-intercostal muscle area and ‘CT intercostal index’ (total CT inter-
costal area/body-mass-index (BMI)) were calculated. Results were collated on electronic spreadsheet (Microsoft 
Excel, Microsoft Corporation).
Correlations between ultrasound, CT measurements, COPD severity (FEV1 and FEV1% predicted) and 
patient factors (BMI and Charlson comorbidity index) were sought.
Statistical analysis. Demographic data were analysed using GraphPad Prism 7 (GraphPad Software Inc., CA 
USA), and correlation analysis utilising R Package (R Foundation for Statistical Computing, Vienna, Austria)29–31. 
Correlation was measured using Pearson correlation coefficient with intra- and inter-rater reliability analysed 
using intraclass correlation coefficient. P-values were not calculated for these data given the limited number of 
subjects and exploratory nature of analyses, apart from partial correlation analysis32 for intercostal ultrasound 
measurements adjusting for repeated single-operator and between measurements with analysis performed using 
SPSS 24 (IBM Corp. 2016. IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY: IBM Corp.).
Data are described by median and interquartile range unless otherwise specified.
Results
Twenty patients underwent ultrasound examinations. Four patients were excluded from CT correlation analysis 
due to inability to format CT images. Ultrasound data from these patients are included in reliability and corre-
lation analyses. Participants typically reported low (52%) or moderate (32%) levels of physical activity on IPAQ. 
Demographic data are recorded in Table 1. Ultrasound findings are recorded in Table 2.
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Intercostal ultrasound. Parasternal intercostal muscles were visualised in all patients, with difficulty in one 
patient with a pes excavatum deformity. Median intercostal thickness (interquartile range) were 4.2 mm (3.3–5.4) 
and 5.3 mm (4.5–7.0) for left second and third parasternal intercostals respectively and 4.1 mm (2.9–5.9) and 
6 mm (3.9–7.5) for second and third right intercostals. (Table 2, Fig. 1) Echogenicity varied between sites, with a 
wide range of values (47–151). (Table 2) When analysing echogenicity data, the impact of acoustic shadowing due 
to ribs was apparent (Fig. 2).
Partial correlation analysis was performed to assess for linear relationships between echogenicity, intercostal 
muscle thickness and density at different sites adjusting for reviewers and two measurements per patient. The 
correlation for muscle thickness between sites ranged from 0.551 to 0.627 (p < 0.001 for all) with density ranging 
from −0.261 to −0.348 (p 0.022 to 0.002). Partial correlation for echogenicity between sites ranged from 0.276 to 
0.444 (p 0.015 to <0.001).
Parasternal intercostal ultrasound and airflow obstruction. Assessment of linear relationships 
between intercostal ultrasound measurements and COPD-related disease markers are summarised in Fig. 5. 
Multiple linear regression analysis was used to estimate the variation in FEV1% with intercostal muscle thick-
ness and density as explanatory factors. Utilising this model, mean intercostal thickness had a moderate positive 
correlation with %predicted FEV1, with r = 0.33. R-values varied between sites, weakest at the left third intercos-
tal space (r = 0.11) and strongest at the left second intercostal (r = 0.36) (Fig. 5). The direction of this relation-
ship supports our hypothesis that greater parasternal intercostal thickness would be associated with better lung 
function.
Figure 1. Parasternal intercostal ultrasound. (A) Position of probe for right second intercostal space. (B) 
Position of probe for left second intercostal space. (C) Typical ultrasound image of parasternal intercostal 
muscle (left 2nd intercostal space. S – subcutaneous fat PM – pectoralis major muscle. R – rib Arrow heads – 
outline of intercostal muscle. Dotted arrow – pleural line.
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Ultrasound-measured mean echogenicity showed a moderate negative correlation with FEV1% predicted, 
(r = −0.32) on regression modelling. Higher echogenicity scores reflect reduced muscle quality, and given CT 
data that intercostal attenuation correlates with FEV1, we had hypothesised that echogenicity would correlate 
negatively. Values for independent sites however varied widely which likely reflects the impact of adjacent ribs 
within the narrow intercostal space, with ultrasound scatter and reflection previously being suggested to account 
for the majority attenuation caused by bone33, which could plausibly explain echogenicity variation.
Ultrasound muscle relationships. Intercostal thickness was weak-to-moderately positively correlated 
to quadriceps thickness (r = 0.15–0.31), with a weak-to-moderate positive correlation to diaphragm thickness 
(r = 0.12–0.67) (Fig. 5). The degree of correlation between FEV1% predicted and quadriceps thickness approxi-
mated that seen in the second intercostal spaces (r = 0.37). The similar strength of correlation is reassuring, par-
ticularly given the strong relationship between quadriceps size and clinically meaningful outcomes in COPD2,12.
CT relationships. CT-measured intercostal mass only weakly correlated with FEV1% predicted (r = 0.13) and 
had a moderate negative correlation with parasternal intercostal thickness, ranging between r = −0.32 to −0.14). 
Figure 2. Pectoralis major, femoral muscle and diaphragm ultrasound images. (A) Typical ultrasound image of 
pectoralis major. (B) Typical ultrasound image and probe position of femoral muscles. (C) Typical ultrasound 
image and probe position of diaphragm thickness. S – subcutaneous fat PMaj – pectoralis major. PMin – 
pectoralis minor R – rib RF – rectus femoris VI – vastus intermedius. Dotted arrow – diaphragmatic surface.
Figure 3. Echogenicity of parasternal intercostal muscle. Typical ultrasound images of parasternal intercostal 
muscle (right 3rd intercostal muscle) with square to measure region of interest for quantitative grayscale analysis 
showing (A) higher echogenicity and (B) lower echogenicity. Insets depict respective histograms of grayscale 
analysis (range 0 [black] to 255 [white]) with mean value recorded.
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Additionally, CT-measured intercostal mass negatively correlated with diaphragm thickness (r = −0.27). 
CT-measured intercostal density had a weak negative correlation with ultrasound measured intercostal 
echogenicity.
Reliability. Intraclass correlation (ICC) for repeated measures (intra-rater reliability) of intercostal muscles 
depended on site, ranging between 0.87–0.97 for thickness, and 0.0.63–0.91 for echogenicity (Table 3). This con-
firms the high intra-rater reliability of ultrasound measurements of parasternal intercostal muscles. Intercostal 
inter-rater reliability was also fair to excellent with ICC between 0.601–0.803 for thickness and 0.685–0.841 for 
echogenicity.
Figure 4. CT image of lateral chest wall internal intercostal muscles. Coronal image from chest CT at lateral arc 
of 1st rib with ROI surrounding boundaries of 3rd–8th internal intercostal muscles.
Demographics n = 20
Sex Male: 16 (80%) Female: 4 (20%)
Age 71.5 (62.3–78.8)
BMI 23.5 (20.9–30)
Current smoker Yes: 4 (20%) No: 16 (80%)
FEV1 (litres) 1.15 (0.99–1.81)
FEV1 (% predicted) 45 (34–74)
Diffusion capacity (% predicted) 44 (34–57)
6-minute walk test distance (metres) (n = 14) 320 (253–455)
Age-adjusted Charlson Comorbidity Index 5 (4–5)
Table 1. All data are median (IQR).
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The reliability of this technique appears to be reduced by obesity, with lower ICC for thickness (0.227–0.577) 
in obese subjects (BMI >30), particularly in the 3rd intercostal space; the increased subcutaneous fat thickness in 
this space may play a role. The ICC for density measurements is also reduced (0.547–0.927). It is worth noting that 
the confidence intervals are wide due to the small number (n = 5) of obese patients.
Discussion
In this pilot study, ultrasound measurement of parasternal intercostal muscles in COPD was feasible and repro-
ducible. Importantly, changes in muscle quantity and quality reflected spirometric disease severity. This novel and 
accessible intercostal muscle assessment method in COPD can be easily repeated, and has potential biomarker 
utility in longitudinal observational and interventional COPD studies.
The relationships found between ultrasound measures of intercostal muscle thickness, echogenicity and 
FEV1% predicted supported our hypotheses. The strength of the positive correlation between intercostal muscle 
thickness and FEV1 was like that between quadriceps thickness and FEV1% predicted. Furthermore, our findings 
of a moderate correlation between quadriceps thickness and FEV1% predicted is similar to other authors13 even 
though the site of measurement differed.
We found that higher muscle echogenicity (indicating poorer muscle quality) negatively correlated with 
COPD severity. Previous histological studies have shown that parasternal intercostal muscles undergo remod-
elling in COPD34, which is thought to reflect muscle recruitment. To our knowledge there are no data looking 
at imaging correlates of these changes, although increased muscle echogenicity on ultrasound is associated with 
increased lipid content on biopsy5,6. Park and colleagues have previously demonstrated that lower lateral intercos-
tal muscle CT-measured attenuation (reflecting muscle fat deposition) is associated with lower FEV116.
Site
Thickness (mm) 
Median (IQR)
Echo intensity 
Median (IQR)
Subcutaneous fat thickness 
(mm) Median (IQR)
Pectoralis major 6.4 (5.7–9.6) 100.2 (81.5–110.3) 6.9 (3.4–9.3)
Left 2nd intercostal 4.2 (3.3–5.4) 110 (96.2–117.5) 3.9 (2.5–6.1)
Left 3rd intercostal 5.3 (3.2–7.0) 105 (86.2–120.4) 4.8 (3.2–7.9)
Right 2nd intercostal 4.1 (2.9–5.9) 105.5 (86.5–113.3) 4.9 (2.9–7.7)
Right 3rd intercostal 6.0 (3.9–7.5) 96.2 (82.2–115.2) 6.1 (3.7–8.9)
Rectus femoris 5.9 (4.6–7.7) 93.6 (88.1–106.2) 5.9 (3.1–7.8)
Vastus intermedius 7.3 (5–8.6) 93.6 (66.8–113.6) 5.9 (3.1–7.8)
Diaphragm 1.97 (1.59–2.25) N/A N/A
Table 2. Ultrasound Findings. IQR – interquartile range.
Figure 5. Correlation matrix. BMI – body mass index Ch.I – Charlson comorbidity index CT.II – CT 
intercostal index CT.IC – Total CT intercostal muscle area CT.MA – CT intercostal muscle mean attenuation 
LIC2.1.T – 2nd left intercostal thickness LIC3.1.T – 3rd left intercostal thickness. RIC2.1.T – 2nd right intercostal 
thickness RIC3.1.T – 3rd right intercostal thickness. LIC2.1.D – 2nd left intercostal density LIC3.1.D – 3rd left 
intercostal density RIC2.1.D – 2nd right intercostal density RIC3.1.D – 3rd right intercostal density Quad.T – 
rectus femoris thickness Dia.T – diaphragm thickness.
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Intraclass correlation for thickness measurements ranged between 0.87–0.97 for a single reader, suggesting 
excellent repeatability. The measures of parasternal muscle echogenicity were less reliable, with ICC between 0.63 
and 0.98; we postulate that this is due to the impact of acoustic shadowing from adjacent ribs. We attempted to 
minimise this by using the square rather than trace method for determining the region of interest for histogram 
analysis. The inter-rater reliability was not as strong for thickness, particularly in the third intercostal spaces 
bilaterally. This is postulated to be due to two factors, firstly related to difficulties reviewing thin muscles (typi-
cally 4–5 mm) from stored images given ultrasound is a ‘real-time’ imaging technique; and secondarily because 
the trangularis sterni muscle is in intercostal spaces caudal to the second space and may have been inadvertently 
included in parasternal intercostal measurements within the third intercostal space.
When evaluating the CT data, there was a negative correlation between ultrasound-measured parasternal 
intercostal thickness and CT-defined intercostal mass, as well as CT- and US-measured echogenicity. The negative 
correlation between the CT and ultrasound measures of density are as expected, as lower density on CT reflects 
increased fat infiltration and therefore poorer muscle quality, whereas the opposite is true with ultrasound echo-
genicity, with increased values representing poorer quality muscles.
In contrast, the negative correlation between CT-measured intercostal mass and ultrasound-defined inter-
costal thickness was surprising. It is worth noting that the action (expiration or inspiration) of internal inter-
costal muscles change as a function of their positioning within the chest wall35, with parasternal intercostals 
acting purely on inspiration, and internal intercostals elsewhere in the chest wall exhibiting an expiratory effect. 
Additionally, there is a gradient of mechanical advantage that decreases moving from caudal to cranial, and ros-
tral to ventral. We postulate that the relationship between intercostal muscle size may reflect different muscle roles 
and recruitment in patients with COPD dependent on chest wall site whereas global muscle quality is similar 
throughout the intercostal muscles, regardless of function. Alternately, a more complex non-linear relationship 
may be present, with definitive conclusions unable to be drawn from our small sample. Either of these hypotheses 
require validation in larger populations (including control subjects) to further elucidate this relationship.
It is worth noting that these results are from scans performed by an experienced single operator, and therefore 
the reproducibility of these results remains to be established. We believe that this technique is relatively simple 
when compared to other commonly used musculoskeletal ultrasound measurements such diaphragm ultrasound, 
and therefore anticipate that parasternal ultrasound will be easily implemented, although this remains to be estab-
lished. We plan to study this in future work.
Future directions. Given the reliability of ultrasound measurement and the direction of relationships as 
expected, we believe that there are benefits in this approach over the CT method. Firstly, the lack of ionising 
radiation is important, particularly given these patients are increasingly likely to undergo CT scanning for other 
indications such as lung cancer screening36. Ultrasound is readily repeatable, opening up new opportunities to 
assess function and response to therapies in patients with COPD, and given the benefits of parenchymal ultra-
sound in patients with acute respiratory failure22, the ready applicability and ability to be added to current imag-
ing protocols shows promise.
It is remains to be seen whether there are differences between stable and exacerbating populations, and 
whether intercostal muscles can undergo dynamic changes described in other muscle groups10. The use of con-
trols would also allow delineation of the role of hyperinflation, although it is worth noting that data in healthy 
individuals did not find thoracic-volume dependent changes in intercostal thickness or intercostal space distance 
in the second interspace bilaterally23. This would support data that the effect of hyperinflation on inspiratory 
muscles is largely due to alterations in direction of rib displacement15, with reduction in change in airway opening 
pressure as intrathoracic pressure increases. We have presented data that therapies aimed at reducing hyperinfla-
tion result in changes in intercostal muscles37.
The data surrounding quadriceps muscle quantity and quality in COPD demonstrate the clinical utility of 
lower limb ultrasound2–4,11,12, and given intercostal bulk is also reduced in COPD but has a more direct impact on 
respiratory mechanics the potential role of this biomarker is wide. We believe that a study comparing quadriceps 
Intra-Reviewer 1 Intra-Reviewer 2 Inter-reviewer
r Confidence interval r Confidence Interval r Confidence interval
RIC2.THICK 0.931 (0.837–0.972) 0.894 (0.757–0.957) 0.601 (0.392–0.789)
RIC3.THICK 0.965 (0.916–0.986) 0.773 (0.519–0.903) 0.682 (0.493–0.839)
LIC2.THICK 0.871 (0.707–0.945) 0.884 (0.734–0.952) 0.803 (0.661–0.905)
LIC3.THICK 0.970 (0.928–0.988) 0.919 (0.810–0.967) 0.668 (0.474–0.830)
RIC2.DEN 0.812 (0.589–0.920) 0.812 (0.591–0.921) 0.685 (0.496–0.840)
RIC3.DEN 0.627 (0.274–0.832) 0.739 (0.457–0.887) 0.722 (0.545–0.861)
LIC2.DEN 0.868 (0.702–0.945) 0.811 (0.588–0.920) 0.817 (0.682–0.913)
LIC3.DEN 0.908 (0.785–0.962) 0.903 (0.771–0.961) 0.841 (0.717–0.927)
Table 3. Intraclass correlation – intra-observer variation. Intra-reviewer 1: ICC of reviewer 1 over two 
measurements. Intra-reviewer 2: ICC of reviewer 2 over two measurements. Inter-reviewer: ICC of all 
measurements for both reviewers by site. RIC2/3.THICK – 2nd/3rd right intercostal thickness measurements. 
LIC2/3.THICK – 2nd/3rd left intercostal thickness measurements. RIC2/3.DEN – 2nd/3rd right intercostal 
echogenicity measurements. LIC2/3.DEN – 2nd/3rd left intercostal echogenicity measurement.
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and intercostal ultrasound in patients with COPD, focussing on patient-specific outcomes such as exercise capac-
ity and exacerbations would provide valuable data further separating the contributions of systemic and respira-
tory muscle quantity and quality changes.
Finally, as previously mentioned, the reproducibility of this technique is yet to be established, and the reliabil-
ity of parasternal intercostal ultrasound with different levels of operator experience requires study.
Conclusion
In stable COPD, ultrasound measurements of parasternal intercostal muscle thickness and density (quality) cor-
relate more strongly with severity of airflow obstruction as measured by FEV1 than CT-measured muscle mass, 
and this measurement is obtained without the need for ionising radiation. Reduced muscle quality (as measured 
by echogenicity) is correlated with muscle thickness. Ultrasound measurements are reproducible, with good to 
excellent intra-rater reliability and fair to excellent inter-rater reliability. Our data suggest US assessment of res-
piratory musculature may provide useful information in clinical assessment of COPD, offering a promising, relia-
ble, and repeatable biomarker for muscle assessment without the risk of ionising radiation. Further study in larger 
cohorts of patients including controls are required to further delineate these relationships.
Data Availability
The datasets generated during and/or analysed during this study are available from the corresponding author on 
reasonable request.
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